Role of macrophages in the candidacidal activity of liposomal amphotericin B

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 214-217

  Mehta, Reeta T ^a,b   Poddar, Sourav ^a   Kalidas, Mamta ^a   Gomez Flores, Ricardo ^a   Dulski, Kim ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; DRUG UPTAKE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031023148     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.214     Document Type: Article

References (15)

1. Mehta RT. Liposomes as drug carriers for polyene antibiotics. Adv Drug Deliv Rev 1989;3:283-306.
2. Weibe VJ, DeGregorio MW. Liposome-encapsulated amphotericin B: a promising new treatment for disseminated fungal infections. Rev Infect Dis 1988;10:1097-101.
3. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996;22(suppl):S133-44.
4. Lopez-Berestein G, Bodey GP, Fainstein V, et al. Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med 1989;149:2533-6.
5. Mehta R, Mehta K, Lopez-Berestein G, Juliano RL. Effect of liposomal amphotericin B on murine macrophages and lymphocytes. Infect Immun 1985;147:429-33.
6. Valdez JC, Meson DE, Sirena A, et al. Induction of the immune response suppression in mice inoculated with Candida albicans. Mycopathologia 1986;93:147-50.
7. 3]-glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods 1986;92:73-7.
8. Mehta RT, McQueen TJ, Keyhani A, Lopez-Berestein G. Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B. Chemotherapy 1994;40:256-64.
9. Pallister CJ, Johnson EM, Warnock DW, Elliot PJ, Reeves DF. Invitro effects of liposome-encapsulated amphotericin B-deoxycholate (fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes. J Antimicrob Chemother 1992; 30:313-20.
10. Chia JKS, Pollack M. Amphotericin B induces tumor necrosis factor production by murine macrophages. J Infect Dis 1989;159:113-6.
11. Wilson E, Thorson L, Speert DP. Enhancement of macrophage Superoxide anion production by amphotericin B. Antimicrob Agents Chemother 1991;35:796-800.
12. Watanabe K, Kagaya K, Yamada T, Fukazawa Y, Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon. Infect Immun 1991;59:S21-8.
13. Vazquez-Torres A, Jones-Carson J, Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect Immun 1995;63:1142-4.
14. Blasi E, Pitzurra L, Puliti M, et al. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect Immun 1995;63:1806-9.
15. Lefkowitz SS, Gelderman MP, Lefkowitz DL, Moguilevsky N, Boleen A. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J Infect Dis 1996;173:1202-7.